AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From Israel Business Arena)
Byline: Batya Feldman
Abiomed (Nasdaq: ABMD) of the US has acquired German start-up Impella CardioSystems. Abiomed will pay $1.8 million in cash and 4.4 million in shares, plus further payments of up to $30 million, depending on milestones to be achieved by Impella. The deal is likely to reach $100 million, the company's estimated value.
Under the acquisition contract, investors in Impella, including Israeli fund Giza Venture Capital, Accelerated Technologies Inc. (ATI), Oxford Bio-Science Partners, Medica Venture Partners, and ABN Amro, will collectively hold the largest stake in Abiomed. Each of the …